Fiduciary Duty in a Screened Mandate: Who Answers for Trade-Offs?

When a mandate carries both a financial objective and a screening standard, governance has to decide which one yields under pressure — before the pressure arrives. The escalation matrix, the disclosure framework, and why it is published rather than kept internal.

A screened mandate contains two obligations that are usually compatible and occasionally are not. Most of the time the screen restricts a universe without materially constraining the financial objective. The governance question is what happens in the minority of cases where it does.

The unhelpful answers are well rehearsed. One is to assert that the tension never arises, which is not credible over a full cycle. The other is to resolve it case by case in the moment, which means the resolution is determined by whoever is in the room and under what commercial pressure.

Deciding in advance

The workable answer is to decide the hierarchy before it is tested, write it down, and publish it. Three things have to be specified.

I. The threshold that triggers referral

A screen that excludes a holding will frequently cost something. Most of the time that cost is immaterial and absorbed without comment. Referral has to be triggered by a defined threshold — expressed as a tracking-error contribution, a concentration change, or a liquidity constraint — rather than by someone's judgement that the moment feels significant.

The threshold's precise level matters less than the fact that it is fixed in advance. A threshold set after the tension appears is not a control.

II. Which objective yields, and who decides

Where the two legs diverge past the threshold, the mandate must state which one gives way and who has authority to decide. In a sustainability-objective mandate the screening standard is constitutive — it is the reason the mandate exists — and the financial expression adapts within it. In a values-aligned mandate the screen restricts a universe, and the honest position is that the financial objective governs inside that restriction.

Both are defensible. What is not defensible is leaving it unstated, because an unstated hierarchy resolves in favour of whichever is more commercially convenient at the time.

III. Best execution still applies to the financial leg

A screening standard constrains what may be held. It says nothing about how a permitted transaction is executed. The best-execution obligation on the financial leg is unaffected, and a screen is never a justification for a worse price, a wider spread or a slower fill.

A screen narrows the universe. It does not lower the standard applied inside it.

The escalation matrix

In practice the framework is a short document:

  1. Detection. Which monitoring identifies divergence, at what frequency, and who owns the alert.
  2. Threshold. The defined level past which the matter is referred rather than absorbed.
  3. Referral. Who it goes to — an investment committee with a defined quorum, not an individual.
  4. Standard applied. The stated hierarchy for that mandate class, plus the best-execution obligation that survives regardless.
  5. Record and disclosure. What is written down, and what is disclosed to the client and when.

Why publish it

Three reasons. It is the only way an investor can assess whether the screen means anything, since a standard nobody can read cannot be relied upon. It constrains the house, which is the point — a published hierarchy is expensive to depart from. And it moves the conversation from assertion to method, which is the only ground on which this discipline can be defended.

The alternative — an internal framework, described in general terms — asks the client to trust a process they are not permitted to examine. For a house arguing that screening should be verifiable, that would be an awkward position to hold.